These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23943969)

  • 1. Recurrent Clostridium difficile infection.
    Gribbins A
    Adv NPs PAs; 2013 Aug; 4(8):13-6; quiz 17. PubMed ID: 23943969
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clostridium difficile].
    Betriu Cabeceran C; Romero Vivas J
    Med Clin (Barc); 1997 Feb; 108(4):146-55. PubMed ID: 9162786
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of first recurrences of Clostridium difficile-associated disease: waiting for new treatment options.
    Louie TJ
    Clin Infect Dis; 2006 Mar; 42(6):765-7. PubMed ID: 16477550
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea.
    Stepan C; Surawicz CM
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):295-305. PubMed ID: 19072422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reining in recurrent Clostridium difficile infection--who's at risk?
    Surawicz CM
    Gastroenterology; 2009 Apr; 136(4):1152-4. PubMed ID: 19250653
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in Clostridium difficile-associated disease.
    Monaghan T; Boswell T; Mahida YR
    Postgrad Med J; 2009 Mar; 85(1001):152-62. PubMed ID: 19351643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clostridium difficile: a serious outpatient infection?].
    Copt C; Christodoulou M; Friolet R; Berclaz R; Bettschart V; Troillet N
    Rev Med Suisse; 2010 Oct; 6(266):1910-3. PubMed ID: 21089556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What measures are necessary in the demonstration of Clostridium difficile toxin?].
    Nguyen HN
    Dtsch Med Wochenschr; 2002 Mar; 127(11):578-9. PubMed ID: 11894182
    [No Abstract]   [Full Text] [Related]  

  • 9. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphopenia as a novel marker of Clostridium difficile infection recurrence.
    Lavergne V; Beauséjour Y; Pichette G; Ghannoum M; Su SH
    J Infect; 2013 Feb; 66(2):129-35. PubMed ID: 23178420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of fidaxomicin in recurrent Clostridium difficile infection in a child.
    Smeltzer S; Hassoun A
    J Antimicrob Chemother; 2013 Jul; 68(7):1688-9. PubMed ID: 23463209
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection.
    Garey KW; Sethi S; Yadav Y; DuPont HL
    J Hosp Infect; 2008 Dec; 70(4):298-304. PubMed ID: 18951661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile and the surgeon.
    Stanley JD; Burns RP
    Am Surg; 2010 Mar; 76(3):235-44. PubMed ID: 20349650
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of surgery in Clostridium difficile colitis.
    Noblett SE; Welfare M; Seymour K
    BMJ; 2009 May; 338():b1563. PubMed ID: 19420031
    [No Abstract]   [Full Text] [Related]  

  • 15. An overview of the diagnosis and management of Clostridium difficile infection.
    Hooper MH; Kelly UM; Marik PE
    Hosp Pract (1995); 2012 Feb; 40(1):119-29. PubMed ID: 22406887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relapsing infections with Clostridium difficile].
    Visser WE; Dingemans-Dumas AM; Bac DJ
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clostridium difficile--an increasing problem].
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jun; 48(6):365. PubMed ID: 23828075
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pseudomembranous colitis].
    García López S; Gomollón F
    Gastroenterol Hepatol; 1998; 21(6):302-13. PubMed ID: 9711015
    [No Abstract]   [Full Text] [Related]  

  • 19. Bezlotoxumab (Zinplava) for prevention of recurrent Clostridium difficile infection.
    Med Lett Drugs Ther; 2017 Mar; 59(1517):49-50. PubMed ID: 28323808
    [No Abstract]   [Full Text] [Related]  

  • 20. Clostridium difficile infection--not just a burden anymore.
    Bulik CC; Kuti JL; Nicolau DP
    Conn Med; 2009 Aug; 73(7):407-11. PubMed ID: 19708320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.